Akkermansia Muciniphila

Pasteurised Akkermansia shows gut and mood benefits: Mouse study

24-Jan-2024 By Stephen Daniells

Supplementation with pasteurized Akkermansia may reduce gut permeability, anxiety-like behaviour and memory impairment in animal models of irritable bowel syndrome (IBS), says a new study.

ResBiotic expands portfolio with prebeet Energy+

09-Jan-2024 By Stephen Daniells

Alabama-based ResBiotic Nutrition has launched its second product—a caffeine-free, 4-in-1 formula to support digestion, energy, skin and heart health.

Does fiber-deprived Akkermansia worsen food allergy?

01-Dec-2023 By Asia Sherman

In a recent study, researchers from the Luxembourg Institute of Health suggested that Akkermansia muciniphila—a bacterium found in the mucus layer of the human intestinal tract—exacerbates food allergies when the gut microbiota of germ-free lab mice is...

Akkermansia decoded: Advance offers opportunity to exploit probiotic's beneficial effects

11-Sep-2023 By Stephen Daniells

Scientists at Duke University in North Carolina are reported to be the first to decode the genetic makeup of Akkermansia, a next-generation probiotic with potential metabolic and immunological benefits.

Grape polyphenols may boost Akkermansia levels, improve the 'intestinal environment': Animal data

03-Feb-2023 By Stephen Daniells

Polyphenols from grapes may indirectly boost levels of Akkermansia muciniphila and improve the inflammatory profile of the intestines, says a new study from Rutgers University.

Elderberry polyphenols may boost Akkermansia levels: Human data

14-Nov-2022 By Stephen Daniells

Daily supplementation with 600 mg of an elderberry extract may boost diversity of the gut microbiota, with specific increases in levels of Akkermansia, says a new study from Austria and Italy.

Akkermansia may alter gene expression in the colon linked to immunity, inflammation: Study

06-Sep-2022 By Stephen Daniells

The potential health benefits of Akkermansia muciniphila may include changing the expression of genes associated with immune pathways, according to a new paper.

Akkermansia’s immune benefits linked to specific phospholipid

24-Aug-2022 By Stephen Daniells

The potential immunomodulatory properties of Akkermansia muciniphila may be linked to a specific type of phosphatidylethanolamine, says a new paper in Nature that deepens our understanding of how this bacterium supports human health.

Researchers leveraging Akkermansia know-how to accelerate probiotic candidate development

18-May-2022 By Stephen Daniells

Knowledge gleaned from the commercialization of Akkermansia muciniphila should lead to an accelerated path to market for a novel probiotic candidate for weight management, says the researcher behind both developments.

Probiotic Akkermansia strain may protect against cognitive dysfunction

31-Aug-2021 By Stephen Daniells

A specific strain of Akkermansia muciniphila may reverse the detrimental cognitive effects of a high-fat, high-cholesterol (HFHC) diet, including for measures of working memory and recognition, says a new study in rats.

AstaReal builds IP for Astaxanthin to support ‘next-gen’ beneficial gut bacteria

10-May-2021 By Stephen Daniells

The US Patent and Trademark Office has granted a patent covering the use of astaxanthin to boost levels of Akkermansia muciniphila.

Akkermansia levels linked to lower obesity risk: American Gut Project data

28-Oct-2020 By Stephen Daniells

High relative abundance of bacteria in the genus Akkermansia may be associated with a lower risk of obesity, according to a new analysis of data from 10,534 participants in the American Gut Project.